Recent findings on drug hypersensitivity in children

被引:1
|
作者
Felix, Mara Morelo Rocha [1 ]
Kuschnir, Fabio Chigres [2 ]
Boechat, Jose Laerte [3 ,4 ]
Castells, Mariana [5 ]
机构
[1] Univ Fed Estado Rio De Janeiro, Sch Med & Surg, Dept Gen Med, Rio De Janeiro, Brazil
[2] Univ Estado Rio De Janeiro, Fac Med, Dept Pediat, Rio De Janeiro, Brazil
[3] Univ Fed Fluminense, Fac Med, Internal Med Dept, Clin Immunol Serv, Niteroi, Brazil
[4] Univ Porto, Fac Med, Dept Pathol, Basic & Clin Immunol Unit, Porto, Portugal
[5] Brigham & Womens Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA USA
来源
FRONTIERS IN ALLERGY | 2024年 / 5卷
关键词
drug hypersensitivity; children; allergy; antibiotic; vaccines; severe cutaneous adverse drug reactions; Stevens-Johnson syndrome; toxic epidermal necrolysis; STEVENS-JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; SYSTEMIC SYMPTOMS DRESS; HOSPITALIZED-PATIENTS; ERYTHEMA MULTIFORME; PENICILLIN ALLERGY; ASSOCIATION; EOSINOPHILIA;
D O I
10.3389/falgy.2024.1330517
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Drug hypersensitivity reactions (DHR) in children have a significant impact on clinical practice and public health. Both under-diagnosis (due to under-reporting) and over-diagnosis (due to the overuse of the term "allergy") are potential issues. The aim of this narrative review is to describe the most recent findings of DHR in children/adolescents and gaps regarding epidemiology, antibiotic allergy, antiepileptic hypersensitivity, vaccine allergy, and severe cutaneous adverse reactions (SCAR) in this age group.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] DRUG HYPERSENSITIVITY
    Yawalkar, N.
    ACTA CLINICA BELGICA, 2009, 64 (06): : 529 - 533
  • [32] EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity
    Brockow, K.
    Ardern-Jones, M. R.
    Mockenhaupt, M.
    Aberer, W.
    Barbaud, A.
    Caubet, J-C
    Spiewak, R.
    Torres, M. Jose
    Mortz, C. G.
    ALLERGOLOGIE, 2020, 43 (08) : 301 - 324
  • [33] Cellular Tests for the Evaluation of Drug Hypersensitivity
    Ariza, Adriana
    Montanez, Maria I.
    Fernandez, Tahia D.
    Perkins, James R.
    Mayorga, Cristobalina
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (45) : 6773 - 6783
  • [34] Advances in the Pathomechanisms of Delayed Drug Hypersensitivity
    Wang, Chuang-Wei
    Divito, Sherrie Jill
    Chung, Wen-Hung
    Hung, Shuen-Iu
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2022, 42 (02) : 357 - 373
  • [35] Diagnosis and management of drug hypersensitivity reactions
    Romano, Antonino
    Torres, Maria J.
    Castells, Mariana
    Sanz, Maria L.
    Blanca, Miguel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (03) : S67 - S73
  • [36] HLA alleles and drug hypersensitivity reactions
    Profaizer, T.
    Eckels, D.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2012, 39 (02) : 99 - 105
  • [37] In Vitro Tests in Drug Hypersensitivity Diagnosis
    Lochmatter, Priska
    Zawodniak, Anna
    Pichler, Werner J.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2009, 29 (03) : 537 - +
  • [38] Pharmacogenomics of Drug Hypersensitivity Technology and Translation
    Kuruvilla, Rebecca
    Scott, Kathryn
    Pirmohamed, Sir Munir
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2022, 42 (02) : 335 - 355
  • [39] Characteristics of liver injury in drug-induced systemic hypersensitivity reactions
    Lee, Taehoon
    Lee, Yoon Su
    Yoon, Sun-Young
    Kim, Sujeong
    Bae, Yun-Jeong
    Kwon, Hyouk-Soo
    Cho, You Sook
    Moon, Hee-Bom
    Kim, Tae-Bum
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (03) : 407 - 415
  • [40] Diagnosing and managing patients with drug hypersensitivity
    Fernandez, Javier
    Dona, Inmaculada
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (01) : 29 - 41